Aldeyra Therapeutics Company Profile (NASDAQ:ALDX)

About Aldeyra Therapeutics

Aldeyra Therapeutics logoAldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company is focused on the development of products for diseases caused by inflammation and inborn errors of metabolism that are caused by naturally occurring toxic and pro-inflammatory chemical species known as aldehydes. The Company has developed a series of aldehyde traps, molecules that are designed to sequester and allow for the degradation of aldehydes. The Company's aldehyde trap, NS2, is a product candidate that is under development for the treatment of allergic conjunctivitis and related rare allergic ocular diseases, noninfectious anterior uveitis, sjogren-larsson syndrome (SLS) and succinic semi-aldehyde dehydrogenase deficiency.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALDX
  • CUSIP:
Key Metrics:
  • Previous Close: $7.35
  • 50 Day Moving Average: $5.93
  • 200 Day Moving Average: $5.61
  • 52-Week Range: $6,245,000.00 - $3.39
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.80
  • P/E Growth: 0.00
  • Market Cap: $46.53M
  • Outstanding Shares: 6,245,000
  • Beta: 0.17
Additional Links:
Companies Related to Aldeyra Therapeutics:

Analyst Ratings

Consensus Ratings for Aldeyra Therapeutics (NASDAQ:ALDX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.25 (104.70% upside)

Analysts' Ratings History for Aldeyra Therapeutics (NASDAQ:ALDX)
Show:
DateFirmActionRatingPrice TargetDetails
7/1/2016Stifel NicolausInitiated CoverageBuy$16.00View Rating Details
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details
2/29/2016Janney Montgomery ScottReiterated RatingBuyView Rating Details
11/13/2015Canaccord GenuityReiterated RatingBuy$15.00View Rating Details
8/13/2015HC WainwrightLower Price TargetBuy$14.00 -> $13.00View Rating Details
3/25/2015Chardan CapitalInitiated CoverageBuy$16.00View Rating Details
1/26/2015LaidlawInitiated CoverageBuy$30.00View Rating Details
12/3/2014Ascendiant Capital MarketsInitiated CoverageBuy$16.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Aldeyra Therapeutics (NASDAQ:ALDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/10/2016Q216($0.44)($0.41)ViewListenView Earnings Details
5/9/2016Q116($0.50)($0.51)ViewN/AView Earnings Details
3/30/2016Q415($0.32)($0.46)ViewListenView Earnings Details
11/12/2015Q315($0.29)($0.35)ViewListenView Earnings Details
8/11/2015Q215($0.35)($0.27)ViewListenView Earnings Details
5/13/2015Q115($0.39)($0.32)ViewListenView Earnings Details
4/14/2015($0.39)($0.31)ViewN/AView Earnings Details
3/19/2015($0.40)($0.30)ViewN/AView Earnings Details
11/10/2014Q314($0.32)($0.36)ViewN/AView Earnings Details
8/4/2014Q214($0.53)($1.56)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aldeyra Therapeutics (NASDAQ:ALDX)
Current Year EPS Consensus Estimate: $-1.69 EPS
Next Year EPS Consensus Estimate: $-1.96 EPS

Dividends

Dividend History for Aldeyra Therapeutics (NASDAQ:ALDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aldeyra Therapeutics (NASDAQ:ALDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Perceptive Advisors LlcMajor ShareholderBuy700,000$5.00$3,500,000.00View SEC Filing  
10/26/2015Perceptive Advisors LlcMajor ShareholderBuy50,000$6.46$323,000.00View SEC Filing  
10/22/2015Perceptive Advisors LlcMajor ShareholderBuy18,020$6.47$116,589.40View SEC Filing  
10/20/2015Perceptive Advisors LlcMajor ShareholderBuy37,145$6.39$237,356.55View SEC Filing  
8/7/2014Martin Joseph JoyceDirectorBuy1,000$3.95$3,950.00View SEC Filing  
8/6/2014C. Boyd ClarkeDirectorBuy3,000$3.69$11,070.00View SEC Filing  
5/7/2014C. Boyd ClarkeDirectorBuy12,500$8.00$100,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aldeyra Therapeutics (NASDAQ:ALDX)
DateHeadline
News IconSteering Attention Towards Earnings; Analysts Weigh in on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Stock - Frisco Fastball (NASDAQ:ALDX)
friscofastball.com - September 23 at 3:50 PM
capitalcube.com logoAldeyra Therapeutics, Inc. :ALDX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 21, 2016 (NASDAQ:ALDX)
www.capitalcube.com - September 21 at 4:20 PM
finance.yahoo.com logoAldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7% (NASDAQ:ALDX)
finance.yahoo.com - September 21 at 9:55 AM
4-traders.com logoALDEYRA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) (NASDAQ:ALDX)
www.4-traders.com - September 14 at 8:59 AM
biz.yahoo.com logoALDEYRA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex (NASDAQ:ALDX)
biz.yahoo.com - September 14 at 8:59 AM
publicnow.com logoAldeyra Therapeutics Appoints Richard H. Douglas to Its Board of Directors (NASDAQ:ALDX)
www.publicnow.com - September 14 at 8:59 AM
finance.yahoo.com logoAldeyra Therapeutics Announces 2016 Research and Development Day (NASDAQ:ALDX)
finance.yahoo.com - September 9 at 8:11 AM
streetinsider.com logoAldeyra Therapeutics (ALDX) COO Young Resigns (NASDAQ:ALDX)
www.streetinsider.com - September 2 at 8:05 AM
biz.yahoo.com logoALDEYRA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ALDX)
biz.yahoo.com - September 2 at 8:05 AM
finance.yahoo.com logoALDEYRA THERAPEUTICS, INC. Financials (NASDAQ:ALDX)
finance.yahoo.com - August 19 at 4:04 PM
News IconAldeyra Announces Second Quarter 2016 Financial Results And Provides Corporate Update (NASDAQ:ALDX)
www.biospace.com - August 11 at 12:37 PM
twst.com logoAldeyra Therapeutics Inc.: Aldeyra Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ALDX)
www.twst.com - August 10 at 10:35 AM
biz.yahoo.com logoALDEYRA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:ALDX)
biz.yahoo.com - August 10 at 10:35 AM
publicnow.com logoAldeyra Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ALDX)
www.publicnow.com - August 10 at 10:35 AM
schaeffersresearch.com logoBuzz Stocks: Valeant Pharmaceuticals Intl Inc, Aldeyra Therapeutics Inc, and Array Biopharma Inc (NASDAQ:ALDX)
www.schaeffersresearch.com - August 9 at 12:10 PM
biz.yahoo.com logoALDEYRA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhib (NASDAQ:ALDX)
biz.yahoo.com - August 9 at 12:10 PM
publicnow.com logoAldeyra Therapeutics Announces Positive Results from a Randomized, Double-Blind, Vehicle-Controlled Clinical Trial of Topical Dermatologic NS2 in Patients With Sjögren-Larsson Syndrome (NASDAQ:ALDX)
www.publicnow.com - August 9 at 12:10 PM
finance.yahoo.com logo4:01 pm Aldeyra Therapeutics will report the results of a clinical trial of NS2 in patients with Sjgren-Larsson Syndrome on August 9, 2016, prior to the market open (NASDAQ:ALDX)
finance.yahoo.com - August 8 at 8:53 PM
publicnow.com logoAldeyra Therapeutics Schedules Conference Call to Present Results of a Randomized, Double-Blind, Vehicle-Controlled Clinical Trial in Sjogren-Larsson Syndrome (NASDAQ:ALDX)
www.publicnow.com - August 8 at 8:53 PM
finance.yahoo.com logoAldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference (NASDAQ:ALDX)
finance.yahoo.com - August 4 at 11:56 AM
twst.com logoAldeyra Therapeutics Inc.: Aldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2016 Financial and Operating Updates (NASDAQ:ALDX)
www.twst.com - August 3 at 12:00 PM
publicnow.com logoAldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2016 Financial and Operating Updates (NASDAQ:ALDX)
www.publicnow.com - August 3 at 12:00 PM
4-traders.com logoSpring Bank Pharmaceuticals : Appoints Dr. Todd C. Brady to its Board of Directors (NASDAQ:ALDX)
www.4-traders.com - July 29 at 3:26 PM
publicnow.com logoSpring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors (NASDAQ:ALDX)
www.publicnow.com - July 28 at 4:18 PM
News IconEquity Roundup: Stock Performance Focus on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Press Telegraph (NASDAQ:ALDX)
presstelegraph.com - July 23 at 7:52 AM
News IconInvestor Update: Earnings and Target Price Recap on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Press Telegraph (NASDAQ:ALDX)
presstelegraph.com - July 21 at 3:27 PM
News IconAldeyra Therapeutics, Inc. (NASDAQ:ALDX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 20 at 10:53 PM
News IconAldeyra Therapeutics (NASDAQ:ALDX) Institutional Investors Sentiment Index Up in 2016 Q1 - Consumer Eagle (NASDAQ:ALDX)
www.consumereagle.com - July 19 at 3:24 PM
ftsenews.co.uk logoNew Broker Ratings For Aldeyra Therapeutics, Inc. (ALDX) - FTSE News (NASDAQ:ALDX)
www.ftsenews.co.uk - July 19 at 3:24 PM
News IconAldeyra Therapeutics, Inc. (NASDAQ:ALDX) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:ALDX)
telanaganapress.com - July 18 at 3:28 PM
News IconHow Analysts Feel About Aldeyra Therapeutics Inc (NASDAQ:ALDX)? - Consumer Eagle (NASDAQ:ALDX)
www.consumereagle.com - July 18 at 8:15 AM
News IconShares Moving Down on the Week: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 17 at 8:09 AM
News IconShares Experiencing a Downtrend: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - TGP (NASDAQ:ALDX)
telanaganapress.com - July 16 at 3:23 PM
News IconAldeyra Therapeutics Incorporated (NASDAQ:ALDX) Short Interest Increased By 3.96% - Consumer Eagle (NASDAQ:ALDX)
www.consumereagle.com - July 16 at 3:23 PM
News IconEye on Stock Volatility for: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 14 at 12:20 PM
News IconAldeyra Therapeutics, Inc. (NASDAQ:ALDX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 13 at 3:28 PM
News IconAldeyra Therapeutics Incorporated (NASDAQ:ALDX) Shorted Shares Increased By 3.96% - Consumer Eagle (NASDAQ:ALDX)
www.consumereagle.com - July 13 at 3:28 PM
News IconTrading Update - Stock Heading Down in Session: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Telanagana Press (NASDAQ:ALDX)
telanaganapress.com - July 12 at 3:27 PM
News IconSession Volatility Review for: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 12 at 3:27 PM
News IconWall Street Ratings and Target Price Views on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Telanagana Press (NASDAQ:ALDX)
telanaganapress.com - July 12 at 8:33 AM
News IconAldeyra Therapeutics Incorporated (NASDAQ:ALDX) Sellers Increased By 3.96% Their Shorts - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 10 at 3:23 PM
News IconStock Moving Up in Trading: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Telanagana Press (NASDAQ:ALDX)
telanaganapress.com - July 7 at 8:42 PM
News IconCan Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 6 at 3:24 PM
fiscalstandard.com logoBroker Outlook For Aldeyra Therapeutics, Inc. (ALDX) - Fiscal Standard (NASDAQ:ALDX)
www.fiscalstandard.com - July 6 at 3:24 PM
fiscalstandard.com logoAldeyra Therapeutics, Inc. (ALDX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:ALDX)
www.fiscalstandard.com - July 4 at 8:12 AM
News IconWhat's Next for Aldeyra Therapeutics Inc After Today's Huge Increase? - Press Telegraph (NASDAQ:ALDX)
presstelegraph.com - July 3 at 8:12 AM
News IconThe Market in 5 Minutes: Tesla, Chipotle battling some bad news (NASDAQ:ALDX)
www.freep.com - July 2 at 11:06 AM
seekingalpha.com logoHealthcare ratings - new coverage #2 - Seeking Alpha (NASDAQ:ALDX)
seekingalpha.com - July 1 at 3:25 PM
News IconTracking Stock Volatility for: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Engelwood Daily (NASDAQ:ALDX)
www.engelwooddaily.com - July 1 at 3:25 PM
News IconShares Headed Up in Session: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) - Telanagana Press (NASDAQ:ALDX)
telanaganapress.com - July 1 at 3:25 PM

Social

Aldeyra Therapeutics (NASDAQ:ALDX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff